At Medical 21, Inc. we have a long, proven history of creating incredible and lasting value in the medical device industry.
Led by founder and CEO Manny Villafaña, Ph.D.Sc., our highly knowledgeable team has made it their mission to improve the quality of life for cardiac bypass surgery patients.
Through decades of collective experience and successes, our team has revolutionized the bypass surgery procedure with a breakthrough artificial graft that eliminates the need for vessel harvesting, which reduces pain, scarring, infection, and healthcare costs.
“Medical 21 embodies the breakthroughs, innovations and materials of the 21st century.”
Dr. Manny Villafaña Medical 21 Founder, Chairman, & CEO
Master Entrepreneur & Living Legend in Medicine
OUR MISSION
To make heart bypass surgery safer, less painful, more accessible, and less expensive
by eliminating the need for vessel harvesting.
We’re working to improve bypass surgery by creating a revolutionary functional artificial blood vessel that will enhance the quality of life and speed the recovery of millions of patients.
OUR PURPOSE
Hearts are complex organs that are difficult to replicate and repair. Artificial grafts and vessels need to be biocompatible, flexible, and strong, but traditional methods often fail, clog, and create complications for the patient.
In order to perform a heart bypass, surgeons must harvest blood vessels from different areas of the body. It’s a slow, painful, and grueling process that leads to longer surgeries and recovery times.
Our technology eliminates the need for this step, which in turn eliminates these negative side effects. We improve a patient’s experience and recovery while reducing costs for the healthcare system.
OUR CORE VALUES
RESHAPE CARDIAC BYPASS SURGERY
We want to improve patient lives by changing how cardiac bypass surgery is performed. We’re eliminating a massive impediment in the procedure while reducing recovery time and complications for patients.
GIVE PATIENTS A BRIGHTER FUTURE
Cardiac bypass surgery is a complex, personal, and challenging process that has a deep impact on patients and their families. Our innovation aims to create a new option to emotionally and physically minimize patient stress.
CREATE IMPACTFUL LASTING VALUE
We have created a small-diameter graft that is strong, flexible, biocompatible, and ready for human trials. By eliminating vessel harvesting, our MAVERICS artificial graft reduces pain, risks, costs, and recovery time.
Connect with M21
info@medical21.com
(612) 429-7630
3700 Annapolis Lane N, Ste 105
Minneapolis, MN 55447